ANG Lifesciences India share news, announcements and annual reports
BSE: 540694Pharmaceuticals & BiotechnologySmall Cap
ANG Lifesciences India Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2017
Last close ₹32.87up ₹0.78 (2.43%)
Share price at the BSE close on 2 Nov 2026. Previous close ₹32.09.
2 Nov: open ₹32.09, high ₹34.50, low ₹31.00
52-week range of traded prices to 2 Nov 2026
₹17.63Low, 30 Mar 2026₹49.69High, 25 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43 Cr3,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −22.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −6.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.47
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,769
ANG Lifesciences India board meetings
102 filed, newest first. Page 2 of 3.
Oct 2022
10 Oct · Board meeting
Meeting on 17 Oct 2022: preferential issue of shares
Aug 2022
29 Aug · Board meeting
Meeting on 5 Sep 2022: annual general meeting14 Aug · Board meeting
5 Aug · Board meeting
Meeting on 14 Aug 2022: quarterly results
May 2022
30 May · Board meeting
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2022: bonus issue, audited results and increase in authorised capital
Mar 2022
21 Mar · Board meeting
Meeting on 29 Mar 2022
Feb 2022
14 Feb · Board meeting
14 Feb · Board meeting
7 Feb · Board meeting
Meeting on 14 Feb 2022: quarterly results
Oct 2021
25 Oct · Board meeting
1 Oct · Board meeting
Meeting on 25 Oct 2021: half yearly results, interim dividend, dividend and annual general meeting
Aug 2021
6 Aug · Board meeting
Jul 2021
30 Jul · Board meeting
Meeting on 6 Aug 2021: increase in authorised capital and bonus issue30 Jul · Board meeting
Jun 2021
30 Jun · Board meeting
24 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Nov 2020
6 Nov · Board meeting
Meeting on 12 Nov 2020: half yearly results
Jul 2020
21 Jul · Board meeting
1 Jul · Board meeting
Meeting on 21 Jul 2020: half yearly results and audited results
Jun 2020
29 Jun · Board meeting
Nov 2019
14 Nov · Board meeting
6 Nov · Board meeting
Meeting on 14 Nov 2019: half yearly results
May 2019
28 May · Board meeting
21 May · Board meeting
Meeting on 28 May 2019: audited results
Nov 2018
14 Nov · Board meeting
Sep 2018
May 2018
30 May · Board meeting